United States Unfractionated Heparin Market Report 2016

Publisher Name :
Date: 10-Oct-2016
No. of pages: 122

Notes:

Sales, means the sales volume of Unfractionated Heparin

Revenue, means the sales value of Unfractionated Heparin

This report studies sales (consumption) of Unfractionated Heparin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (US)

- Bayer Healthcare AG (Germany)

- GlaxoSmithKline Plc. (UK)

- Boehringer Ingelheim (Germany)

- Sanofi S.A. (France)

- Abbott India Limited (India)

- Aspen Holdings (South Africa)

- Bristol-Myers Squibb Company (US)

- Eisai Inc. (US)

- Mitsubishi Tanabe Pharma Corporation (Japan)

- Teva Pharmaceutical Industries Ltd. (Israel)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Unfractionated Heparin in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Unfractionated Heparin Market Report 2016

Table of Contents
United States Unfractionated Heparin Market Report 2016
1 Unfractionated Heparin Overview
1.1 Product Overview and Scope of Unfractionated Heparin
1.2 Classification of Unfractionated Heparin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Unfractionated Heparin
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Unfractionated Heparin (2011-2021)
1.4.1 United States Unfractionated Heparin Sales and Growth Rate (2011-2021)
1.4.2 United States Unfractionated Heparin Revenue and Growth Rate (2011-2021)
2 United States Unfractionated Heparin Competition by Manufacturers
2.1 United States Unfractionated Heparin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Unfractionated Heparin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Unfractionated Heparin Average Price by Manufactures (2015 and 2016)
2.4 Unfractionated Heparin Market Competitive Situation and Trends
2.4.1 Unfractionated Heparin Market Concentration Rate
2.4.2 Unfractionated Heparin Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Unfractionated Heparin Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Unfractionated Heparin Sales and Market Share by Type (2011-2016)
3.2 United States Unfractionated Heparin Revenue and Market Share by Type (2011-2016)
3.3 United States Unfractionated Heparin Price by Type (2011-2016)
3.4 United States Unfractionated Heparin Sales Growth Rate by Type (2011-2016)
4 United States Unfractionated Heparin Sales (Volume) by Application (2011-2016)
4.1 United States Unfractionated Heparin Sales and Market Share by Application (2011-2016)
4.2 United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Unfractionated Heparin Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (US)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Unfractionated Heparin Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
5.2.2 Unfractionated Heparin Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Healthcare AG (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
5.3.2 Unfractionated Heparin Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
5.4.2 Unfractionated Heparin Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Boehringer Ingelheim (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
5.5.2 Unfractionated Heparin Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Sanofi S.A. (France) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
5.6.2 Unfractionated Heparin Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Abbott India Limited (India) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
5.7.2 Unfractionated Heparin Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Aspen Holdings (South Africa) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
5.8.2 Unfractionated Heparin Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
5.9.2 Unfractionated Heparin Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Eisai Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
5.10.2 Unfractionated Heparin Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)
6 Unfractionated Heparin Manufacturing Cost Analysis
6.1 Unfractionated Heparin Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Unfractionated Heparin
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Unfractionated Heparin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Unfractionated Heparin Market Forecast (2016-2021)
10.1 United States Unfractionated Heparin Sales, Revenue Forecast (2016-2021)
10.2 United States Unfractionated Heparin Sales Forecast by Type (2016-2021)
10.3 United States Unfractionated Heparin Sales Forecast by Application (2016-2021)
10.4 Unfractionated Heparin Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Unfractionated Heparin
Table Classification of Unfractionated Heparin
Figure United States Sales Market Share of Unfractionated Heparin by Type in 2015
Table Application of Unfractionated Heparin
Figure United States Sales Market Share of Unfractionated Heparin by Application in 2015
Figure United States Unfractionated Heparin Sales and Growth Rate (2011-2021)
Figure United States Unfractionated Heparin Revenue and Growth Rate (2011-2021)
Table United States Unfractionated Heparin Sales of Key Manufacturers (2015 and 2016)
Table United States Unfractionated Heparin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Unfractionated Heparin Sales Share by Manufacturers
Figure 2016 Unfractionated Heparin Sales Share by Manufacturers
Table United States Unfractionated Heparin Revenue by Manufacturers (2015 and 2016)
Table United States Unfractionated Heparin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Unfractionated Heparin Revenue Share by Manufacturers
Table 2016 United States Unfractionated Heparin Revenue Share by Manufacturers
Table United States Market Unfractionated Heparin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Unfractionated Heparin Average Price of Key Manufacturers in 2015
Figure Unfractionated Heparin Market Share of Top 3 Manufacturers
Figure Unfractionated Heparin Market Share of Top 5 Manufacturers
Table United States Unfractionated Heparin Sales by Type (2011-2016)
Table United States Unfractionated Heparin Sales Share by Type (2011-2016)
Figure United States Unfractionated Heparin Sales Market Share by Type in 2015
Table United States Unfractionated Heparin Revenue and Market Share by Type (2011-2016)
Table United States Unfractionated Heparin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Unfractionated Heparin by Type (2011-2016)
Table United States Unfractionated Heparin Price by Type (2011-2016)
Figure United States Unfractionated Heparin Sales Growth Rate by Type (2011-2016)
Table United States Unfractionated Heparin Sales by Application (2011-2016)
Table United States Unfractionated Heparin Sales Market Share by Application (2011-2016)
Figure United States Unfractionated Heparin Sales Market Share by Application in 2015
Table United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
Figure United States Unfractionated Heparin Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Unfractionated Heparin Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Unfractionated Heparin Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Unfractionated Heparin Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Unfractionated Heparin Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Unfractionated Heparin Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Unfractionated Heparin Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Unfractionated Heparin Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Unfractionated Heparin Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Unfractionated Heparin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Unfractionated Heparin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Unfractionated Heparin
Figure Manufacturing Process Analysis of Unfractionated Heparin
Figure Unfractionated Heparin Industrial Chain Analysis
Table Raw Materials Sources of Unfractionated Heparin Major Manufacturers in 2015
Table Major Buyers of Unfractionated Heparin
Table Distributors/Traders List
Figure United States Unfractionated Heparin Production and Growth Rate Forecast (2016-2021)
Figure United States Unfractionated Heparin Revenue and Growth Rate Forecast (2016-2021)
Table United States Unfractionated Heparin Production Forecast by Type (2016-2021)
Table United States Unfractionated Heparin Consumption Forecast by Application (2016-2021)
  • Asia Pacific Makeup Market To Grow Owing To Impactful Promotion And Progress Of Distribution Networks
    The Asia Pacific makeup market is one of the most assorted and active markets in the cosmetics industry throughout the world and is projected to grow at a CAGR of 7.1% between 2013 and 2019. The makeup market in Asia Pacific is assessed to be worth US$22.31 billion by 2019. The world-wide market was at an approximation of US$14.76 [...]
  • Growing Demand in Emergent Markets To Boost Bakery Ingredients Market
    The baking ingredients market is predictable to grow at a CAGR of 5.2% from 2015 to reach an estimated value of US$ 15.19 billion by 2020. Evolving economies throughout the globe have been displaying demand for bakery ingredients at a greater rate in agreement with the economic growth. Numerous companies have been occupied on refining [...]
  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • United States Fish Oil Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 124
    Notes: Sales, means the sales volume of Fish Oil Revenue, means the sales value of Fish Oil This report studies sales (consumption) of Fish Oil in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - TripleNine Group - COPEINCA - Austevoll Seafood ASA - China Fishery Group - FF Skagen A/S - Pesquera Diamante S.A. - Camanchaca - OLVEA Fish Oils......
  • United States Dental Braces Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 107
    Notes: Sales, means the sales volume of Dental Braces Revenue, means the sales value of Dental Braces This report studies sales (consumption) of Dental Braces in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Henry Schein - 3M Unitek - GC Orthodontics - FORESTADENT - Patterson Dental - American Orthodontics - Dentsply - Ormco - Den......
  • United States Toxoid Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 97
    Notes: Sales, means the sales volume of Toxoid Vaccine Revenue, means the sales value of Toxoid Vaccine This report studies sales (consumption) of Toxoid Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - CSL Limited - GlaxoSmithKline - Merck - Sanofi Pasteur Market Segment by States, covering - California - Texas - New Yor......
  • United States Synthetic Peptide Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Synthetic Peptide Vaccine Revenue, means the sales value of Synthetic Peptide Vaccine This report studies sales (consumption) of Synthetic Peptide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Artificial Cell Technologies - Benovus Bio - Bionor Pharma - Circassia - Celgene Corporation - Galena Biophar......
  • United States Subunit Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 103
    Notes: Sales, means the sales volume of Subunit Vaccine Revenue, means the sales value of Subunit Vaccine This report studies sales (consumption) of Subunit Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Astellas - CSL Limited - Emergent BioSolutions - GlaxoSmithKline - Johnson&Johnson - MedImmune - Merck - Serum Institute......
  • United States Rotavirus Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 95
    Notes: Sales, means the sales volume of Rotavirus Vaccine Revenue, means the sales value of Rotavirus Vaccine This report studies sales (consumption) of Rotavirus Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Astellas Pharma - CSL Limited - Emergent BioSolutions - GlaxoSmithKline - Johnson&Johnson - MedImmune - Merck M......
  • United States Polio Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 96
    Notes: Sales, means the sales volume of Polio Vaccine Revenue, means the sales value of Polio Vaccine This report studies sales (consumption) of Polio Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Astellas Pharma - CSL Limited - Emergent BioSolutions - GlaxoSmithKline - Johnson&Johnson - MedImmune - Merck Market Segmen......
  • United States Peptide Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 113
    Notes: Sales, means the sales volume of Peptide Vaccine Revenue, means the sales value of Peptide Vaccine This report studies sales (consumption) of Peptide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Artificial Cell Technologies - Benovus Bio - Bionor Pharma - Circassia - Celgene Corporation - Galena Biopharma - Immatics biotechno......
  • United States MMR Vaccine Market Report 2017
    Published: 27-Feb-2017        Price: US 3800 Onwards        Pages: 100
    Notes: Sales, means the sales volume of MMR Vaccine Revenue, means the sales value of MMR Vaccine This report studies sales (consumption) of MMR Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Astellas Pharma Inc - CSL Limited - Emergent BioSolutions, Inc - GlaxoSmithKline - Johnson&Johnson - MedImmune - Merck - Pfizer - ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs